Meningitis: Vaccination

(asked on 29th February 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the (a) adequacy and (b) availability of meningitis B vaccine stocks across the UK; and if he will make a statement.


Answered by
 Portrait
Jane Ellison
This question was answered on 3rd March 2016

Current availability of the Meningococcal B vaccine for the national immunisation programme is adequate with a central buffer of stock being maintained (and monitored) to ensure security of supply. The vaccine continues to be delivered to eligible infants as part of the National Health Service childhood immunisation schedule. However, the manufacturers of Bexsero, GlaxoSmithKline, have confirmed that they have supply constraints for the private market due to unexpected Global demand.

Reticulating Splines